Theon International (ENXTAM:THEON) has recently drawn attention on the Amsterdam exchange. Fresh moves in its share price raise questions about how investors are valuing the company’s growth and profitability this month.

See our latest analysis for Theon International.

This latest share price action at €27.95 comes on the heels of Theon International’s impressive rally so far this year, with momentum clearly building. Year-to-date share price returns sit at 111.74%, and the 1-year total shareholder return is an eye-catching 210.63%. Despite a bumpier ride in recent weeks, this kind of performance suggests a major shift in investor confidence or future growth expectations.

If this kind of explosive run has you thinking about what else could be next, now is the perfect moment to broaden your outlook and explore fast growing stocks with high insider ownership

But with Theon International trading well below analyst price targets and showing annual growth in both revenue and net income, investors have to ask: Is there genuine value left on the table, or is all that upside already priced in?

With Theon International currently trading at a price-to-earnings (P/E) ratio of 26.9x, investors must consider whether this premium multiple reflects genuine long-term potential or excessive optimism compared to peers and fair value measures.

The P/E ratio expresses how much investors are willing to pay for each euro of the company’s earnings. For a fast-growing business like Theon International, a higher multiple can sometimes be justified by market expectations of sustained earnings acceleration.

In this case, the company’s P/E of 26.9x is well above the peer group average of 19.4x and also sits slightly above its estimated fair P/E of 24.6x. This suggests that the market may be pricing in robust future growth, though the level is higher than what both statistical models and industry comparables would imply as reasonable equilibrium.

However, compared to the broader European Aerospace & Defense industry, where the average P/E is 32.3x, Theon International trades at a discount. This highlights its relative value within the sector but a premium against direct peers.

Explore the SWS fair ratio for Theon International

Result: Price-to-Earnings of 26.9x (OVERVALUED)

However, weaker-than-expected profit growth or sudden shifts in industry demand could quickly challenge the current bullish outlook for Theon International.

Find out about the key risks to this Theon International narrative.

Looking at Theon International from the perspective of our SWS DCF model, the story shifts. While the P/E ratio hints at rich pricing, the DCF model indicates the shares are trading about 24.6% below their estimated fair value. Is the market underestimating future cash flows, or are risks still present?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Theon International for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 881 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

If you’d rather follow your own logic or feel there’s more to uncover in the numbers, you can quickly build your personal view using Do it your way.

A great starting point for your Theon International research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.

Don’t stop at just one idea. The market is full of emerging winners. Let these handpicked stock groups help you spot your next potential outperformer.

Uncover growth potential by scanning these 881 undervalued stocks based on cash flows, which is filled with stocks trading below their intrinsic worth and positioned for future upside.

Catch the next tech wave by investigating these 27 AI penny stocks, featuring innovative companies pushing boundaries in artificial intelligence.

Tap into future healthcare breakthroughs with these 31 healthcare AI stocks, focusing on firms revolutionizing medicine through advanced AI solutions.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include THEON.AS.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com